USP11 and neurodegenerative disease: Future work will reveal more details of the regulatory mechanisms via which USP11 restricts autophagy, which is of broader interest because our data raised the possibility that autophagy activation by inhibiting USP11 could be a therapeutic option to alleviate symptoms of proteotoxicity, which is a major hallmark of neurodegenerative diseases.